Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Eur J Pharm Sci. 2013 Mar 12;48(4-5):803-11. doi: 10.1016/j.ejps.2013.01.002. Epub 2013 Jan 26.
Hyperglycemia is one of the major risk factors leading to vascular complications in clinical diabetes mellitus. Ginkgo biloba extract (GBE), an antioxidant herbal medicine, possesses anti-inflammatory effects. We examined whether GBE can reduce high glucose-induced endothelial adhesiveness to monocytes, an in vitro sign mimicking in vivo early atherogenesis, through selective regulation of heme oxygenase (HO)-1 expression.
Human aortic endothelial cells (HAECs) were cultured with normal glucose or high glucose (25 mM) for 4 days and subsequently combined with GBE (EGb761, Dr. Willmar Schwabe, Karlsruhe, Germany) treatment in the last 18 h of the 4-day period. The endothelial reactive oxygen species (ROS) generation, adhesion molecule expression and the adhesiveness to monocytes were examined. The specific signal pathways such as HO-1 were also examined.
High glucose increased ROS generation, adhesion molecule expression and the adhesiveness to monocytes in HAECs. These high glucose-induced phenomena could be suppressed by GBE (100 μg/ml)-induced HO-1 expression in a dose-dependent and time-dependent manner. In addition, jun N-terminal kinases inhibitor or phosphoinositide 3 kinase inhibitor could reduce GBE-induced HO-1 expression. Furthermore, HO-1 inhibitor, HO-1 siRNA, endothelial nitric oxide synthase (eNOS) siRNA, or nuclear factor erythroid 2-related factor (Nrf) 2 siRNA blocked the cytoprotective effects of GBE. Meanwhile, p38/mitogen-activated protein kinase (MAPK) inhibitor could also reduce the effects of GBE on HO-1 induction.
GBE could reduce high glucose-induced endothelial adhesion via enhancing HO-1 expression through the Akt/eNOS and p38/MAPK pathways. Our findings suggest a potential strategy targeting on HO-1 induction by GBE for endothelial protection in the presence of high glucose such as that in diabetes mellitus.
高血糖是导致临床糖尿病血管并发症的主要危险因素之一。银杏叶提取物(GBE)是一种抗氧化草药,具有抗炎作用。我们研究了 GBE 是否可以通过选择性调节血红素加氧酶(HO)-1 的表达来减少高葡萄糖诱导的内皮细胞对单核细胞的粘附,这是一种模拟体内早期动脉粥样硬化形成的体外迹象。
将人主动脉内皮细胞(HAEC)在正常葡萄糖或高葡萄糖(25mM)中培养 4 天,然后在最后 18 小时内与 GBE(Dr. Willmar Schwabe,Karlsruhe,德国的 EGb761)联合处理。检查内皮细胞活性氧(ROS)的产生、粘附分子的表达以及与单核细胞的粘附性。还检查了 HO-1 等特定信号通路。
高葡萄糖增加了 HAEC 中的 ROS 生成、粘附分子表达和与单核细胞的粘附。这些高葡萄糖诱导的现象可以通过 GBE(100μg/ml)诱导的 HO-1 表达以剂量和时间依赖的方式得到抑制。此外,Jun N 末端激酶抑制剂或磷酸肌醇 3 激酶抑制剂可以减少 GBE 诱导的 HO-1 表达。此外,HO-1 抑制剂、HO-1 siRNA、内皮型一氧化氮合酶(eNOS)siRNA 或核因子红细胞 2 相关因子(Nrf)2 siRNA 阻断了 GBE 的细胞保护作用。同时,p38/丝裂原激活蛋白激酶(MAPK)抑制剂也可以减少 GBE 对 HO-1 诱导的作用。
GBE 可以通过增强 HO-1 表达来减少高葡萄糖诱导的内皮细胞粘附,通过 Akt/eNOS 和 p38/MAPK 途径。我们的研究结果表明,在高葡萄糖(如糖尿病)存在的情况下,通过 GBE 诱导 HO-1 表达可能是一种内皮保护的潜在策略。